CEO AND FOUNDER OF SENTHERA
Mr. Tandakha Ndiaye DIEYE is a Full Professor at Cheikh Anta Diop University (UCAD) in Dakar and universities in Senegal. He is an internationally renowned researcher who has dedicated his career to improving public health outcomes through research in the immunology of infectious diseases and congenital immunodeficiencies.
From the beginning of his specialization in immunology at the Christian de Duve Institute of Cellular Pathology ICP (UCL) then at the ULB in Brussels, he quickly invested in diagnosis, prevention through vaccination, treatment and the follow-up of patients with immunodeficiencies.
Mr. Dieye has been one of the pioneers in the diagnosis of congenital immunodeficiencies in Senegal since 2009, which led to the creation of the Senegalese association of people with primary immunodeficiencies (ASDIP). Becoming President of the African Society For Immunodeficiencies (ASID) in 2017, he made several pleas for better accessibility to biological medicines for people with these congenital anomalies.
Throughout his studies, Prof. Dieye has played a crucial role in improving the teaching of vaccinology and immunology in Africa, and especially in the continuous effort to fight against the COVID-19 pandemic. Mr Dieye is also a WHO consultant, a member of the regional committee to verify the elimination of measles and rubella through vaccination in Africa. Prof. Dieye's work has not gone unnoticed, and he has been awarded numerous times for his contributions to global health. His research has been published in prestigious medical journals, and he is frequently invited to speak at conferences and symposiums around the world. The advent of the COVID-19 pandemic has shown the urgency for the African continent to locally have quality and accessible biological medicines. Developing local industry is becoming a necessity for the health of the African population.
Supporting infos
Congenital immunodeficiencies Acquired immunodeficiencies
Cancers and degenerative and autoimmune pathologies
Neglected, emerging and re-emerging diseases
Transplants and grafts , Snake bites
Goals
Immunotherapy, which includes Serums, Immunoglobulins, Monoclonal Antibodies, Recombinant Proteins and other Immunosuppressant or Immunomodulatory Molecules, will be a necessity for Africa in the management of the health of its population.
Antivenom immunotherapy
Develop specific antivenom immunotherapy (IAV)
Sera and immunoglobulins
Provide Africa with the amount of serum and immunoglobulins it needs
Monoclonal Antibodies
Facilitate the production of Monoclonal Antibodies for immunotherapy
Immune molecules
Reinforce the production of immune molecules intended for the treatment of infectious and non-infectious pathologies
Product accessibility
Promoting equitable access to EPI serums
Positive impact
Reduce morbidity and mortality in Africa
Training
Promote training in research and development.
Workspace
Reducing the "brain drain" by providing young Africans with an adequate working environment
Meet Our Specialist
Behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts. Separated they live in Bookmarks grove right
Doctors Achievements
Behind the word mountains, far from the countries Vokalia and Consonantia, there live the blind texts the word.
Service Recipient Says
Oxmox advised her not to do so, because there were thousands of bad Commas, wild Question Marks and devious.
Kolis Muller
Oxmox advised her not to do so, because there were thousands of bad Commas, wild Question Marks and devious.
Kolis Muller
English 
French
Oxmox advised her not to do so, because there were thousands of bad Commas, wild Question Marks and devious.
Kolis Muller NY Citizen